Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20499354rdf:typepubmed:Citationlld:pubmed
pubmed-article:20499354lifeskim:mentionsumls-concept:C0026162lld:lifeskim
pubmed-article:20499354lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:20499354lifeskim:mentionsumls-concept:C0262950lld:lifeskim
pubmed-article:20499354lifeskim:mentionsumls-concept:C0027662lld:lifeskim
pubmed-article:20499354lifeskim:mentionsumls-concept:C0022646lld:lifeskim
pubmed-article:20499354lifeskim:mentionsumls-concept:C0221002lld:lifeskim
pubmed-article:20499354lifeskim:mentionsumls-concept:C0009566lld:lifeskim
pubmed-article:20499354lifeskim:mentionsumls-concept:C0205082lld:lifeskim
pubmed-article:20499354lifeskim:mentionsumls-concept:C1833334lld:lifeskim
pubmed-article:20499354lifeskim:mentionsumls-concept:C0205329lld:lifeskim
pubmed-article:20499354lifeskim:mentionsumls-concept:C0205231lld:lifeskim
pubmed-article:20499354lifeskim:mentionsumls-concept:C0332183lld:lifeskim
pubmed-article:20499354pubmed:issue11lld:pubmed
pubmed-article:20499354pubmed:dateCreated2010-10-27lld:pubmed
pubmed-article:20499354pubmed:abstractTextDifferences in bone mineral density (BMD) patterns have been recently reported between multiple endocrine neoplasia type 1-related primary hyperparathyroidism (HPT/MEN1) and sporadic primary HPT. However, studies on the early and later outcomes of bone/renal complications in HPT/MEN1 are lacking. In this cross-sectional study, performed in a tertiary academic hospital, 36 patients cases with uncontrolled HPT from 8 unrelated MEN1 families underwent dual-energy X-ray absorptiometry (DXA) scanning of the proximal one-third of the distal radius (1/3DR), femoral neck, total hip, and lumbar spine (LS). The mean age of the patients was 38.9?±?14.5 years. Parathyroid hormone (PTH)/calcium values were mildly elevated despite an overall high percentage of bone demineralization (77.8%). In the younger group (<50 years of age), demineralization in the 1/3DR was more frequent, more severe, and occurred earlier (40%; Z-score -1.81?±?0.26). The older group (>50 years of age) had a higher frequency of bone demineralization at all sites (p?<?.005) and a larger number of affected bone sites (p?<?.0001), and BMD was more severely compromised in the 1/3DR (p?=?.007) and LS (p?=?.002). BMD values were lower in symptomatic (88.9%) than in asymptomatic HPT patients (p?<?.006). Patients with long-standing HPT (>10 years) and gastrinoma/HPT presented significantly lower 1/3DR BMD values. Urolithiasis occurred earlier (<30 years) and more frequently (75%) and was associated with related renal comorbidities (50%) and renal insufficiency in the older group (33%). Bone mineral- and urolithiasis-related renal complications in HPT/MEN1 are early-onset, frequent, extensive, severe, and progressive. These data should be considered in the individualized clinical/surgical management of patients with MEN1-associated HPT.lld:pubmed
pubmed-article:20499354pubmed:languageenglld:pubmed
pubmed-article:20499354pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20499354pubmed:citationSubsetIMlld:pubmed
pubmed-article:20499354pubmed:statusMEDLINElld:pubmed
pubmed-article:20499354pubmed:monthNovlld:pubmed
pubmed-article:20499354pubmed:issn1523-4681lld:pubmed
pubmed-article:20499354pubmed:authorpubmed-author:ToledoSergio...lld:pubmed
pubmed-article:20499354pubmed:authorpubmed-author:ToledoRodrigo...lld:pubmed
pubmed-article:20499354pubmed:authorpubmed-author:LourençoDelma...lld:pubmed
pubmed-article:20499354pubmed:authorpubmed-author:CoutinhoFlavi...lld:pubmed
pubmed-article:20499354pubmed:authorpubmed-author:MontenegroFab...lld:pubmed
pubmed-article:20499354pubmed:authorpubmed-author:Correia-DeurJ...lld:pubmed
pubmed-article:20499354pubmed:copyrightInfo© 2010 American Society for Bone and Mineral Research.lld:pubmed
pubmed-article:20499354pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20499354pubmed:volume25lld:pubmed
pubmed-article:20499354pubmed:ownerNLMlld:pubmed
pubmed-article:20499354pubmed:authorsCompleteYlld:pubmed
pubmed-article:20499354pubmed:pagination2382-91lld:pubmed
pubmed-article:20499354pubmed:meshHeadingpubmed-meshheading:20499354...lld:pubmed
pubmed-article:20499354pubmed:meshHeadingpubmed-meshheading:20499354...lld:pubmed
pubmed-article:20499354pubmed:meshHeadingpubmed-meshheading:20499354...lld:pubmed
pubmed-article:20499354pubmed:meshHeadingpubmed-meshheading:20499354...lld:pubmed
pubmed-article:20499354pubmed:meshHeadingpubmed-meshheading:20499354...lld:pubmed
pubmed-article:20499354pubmed:meshHeadingpubmed-meshheading:20499354...lld:pubmed
pubmed-article:20499354pubmed:meshHeadingpubmed-meshheading:20499354...lld:pubmed
pubmed-article:20499354pubmed:meshHeadingpubmed-meshheading:20499354...lld:pubmed
pubmed-article:20499354pubmed:meshHeadingpubmed-meshheading:20499354...lld:pubmed
pubmed-article:20499354pubmed:meshHeadingpubmed-meshheading:20499354...lld:pubmed
pubmed-article:20499354pubmed:meshHeadingpubmed-meshheading:20499354...lld:pubmed
pubmed-article:20499354pubmed:meshHeadingpubmed-meshheading:20499354...lld:pubmed
pubmed-article:20499354pubmed:meshHeadingpubmed-meshheading:20499354...lld:pubmed
pubmed-article:20499354pubmed:meshHeadingpubmed-meshheading:20499354...lld:pubmed
pubmed-article:20499354pubmed:meshHeadingpubmed-meshheading:20499354...lld:pubmed
pubmed-article:20499354pubmed:meshHeadingpubmed-meshheading:20499354...lld:pubmed
pubmed-article:20499354pubmed:meshHeadingpubmed-meshheading:20499354...lld:pubmed
pubmed-article:20499354pubmed:year2010lld:pubmed
pubmed-article:20499354pubmed:articleTitleEarly-onset, progressive, frequent, extensive, and severe bone mineral and renal complications in multiple endocrine neoplasia type 1-associated primary hyperparathyroidism.lld:pubmed
pubmed-article:20499354pubmed:affiliationEndocrine Genetics Unit (LIM-25), Division of Endocrinology, University of São Paulo School of Medicine, São Paulo, Brazil.lld:pubmed
pubmed-article:20499354pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20499354pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed